The defensive effect of benfotiamine in sodium arsenite-induced experimental vascular endothelial dysfunction

Biological Trace Element Research

Volumn 137, Issue 1, 2010, Pages 96-109

  Verma, Sanjali ^a   Reddy, Krishna ^a   Balakumar, Pitchai ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Benfotiamine; Endothelial dysfunction; eNOS; Sodium arsenite

Indexed keywords

ARSENITE SODIUM; ATORVASTATIN; BENFOTIAMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; NONHUMAN; OXIDATIVE STRESS; RAT; SCANNING ELECTRON MICROSCOPY; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR RING;

ANIMALS; ARSENITES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; MICROSCOPY, ELECTRON, SCANNING; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; RATS; RATS, WISTAR; SODIUM COMPOUNDS; THIAMINE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VASODILATION;

RATTUS;

EID: 77955510458     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12011-009-8567-7     Document Type: Article

References (41)

1. M Le Brocq JS Leslie P Milliken IL Megson 2008 Endothelial dysfunction: from molecular mechanism to measurements, clinical implications and therapeutic opportunities Antioxid Redox Signal 10 1631 1674 10.1089/ars.2007.2013 18598143 (Pubitemid 351931927)
2. RJ Esper RA Nordaby JO Vilarino A Paragano JL Cacharron RA Machado 2006 Endothelial dysfunction: a comprehensive appraisal Cardiovasc Diabetol 5 4 10.1186/1475-2840-5-4 16504104
3. P Balakumar S Jindal DI Shah M Singh 2007 Experimental models for vascular endothelial dysfunction Trends Med Res 2 12 20 10.3923/tmr.2007.12.20 1:CAS:528:DC%2BD2sXhtV2rsLnF
4. RF Furchgott JV Zawadzki 1980 The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 373 376 10.1038/288373a0 1:CAS:528:DyaL3MXhtFCktbY%3D 6253831 (Pubitemid 11169009)
5. LJ Ignarro 1989 Endothelium-derived nitric oxide, actions and properties FASEB J 3 31 36 1:CAS:528:DyaL1MXmvFCktw%3D%3D 2642868
6. P Balakumar T Kaur M Singh 2008 Potential target sites to modulate vascular endothelial dysfunction: current perspectives and future directions Toxicology 245 49 64 10.1016/j.tox.2007.12.011 1:CAS:528:DC%2BD1cXitlKrtb8%3D 18242815
7. F Desjardins JL Balligand 2006 Nitric oxide-dependent endothelial function and cardiovascular disease Acta Clin Belg 61 326 334 1:STN:280:DC%2BD2s7isVymuw%3D%3D 17323842
8. PO Bonetti LO Lerman A Lerman 2003 Endothelial dysfunction: a marker of atherosclerotic risk Arterioscler Thromb Vasc Bio 23 168 175 10.1161/01.ATV.0000051384.43104.FC 1:CAS:528:DC%2BD3sXptFyrsw%3D%3D (Pubitemid 36231924)
9. P Balakumar RU Koladiya S Ramasamy A Rathinavel M Singh 2008 Pharmacological interventions to prevent vascular endothelial dysfunction: future directions J Health Sci 54 1 16 10.1248/jhs.54.1 1:CAS:528: DC%2BD1cXisFGhu7o%3D (Pubitemid 351757434)
10. Z Yang XF Ming 2006 Recent advances in understanding endothelial dysfunction in atherosclerosis Clin Med Res 4 53 56 10.3121/cmr.4.1.53 16595793
11. C Giansante N Fiotti 2006 Insights into human hypertension: the role of endothelial dysfunction J Human Hypertens 20 725 726 10.1038/sj.jhh.1001951 1:CAS:528:DC%2BD28Xpsl2ru70%3D (Pubitemid 44430669)
12. T Heitzer T Schlinzig K Krohn T Meinertz M Munzel 2001 Endothelial dysfunction, oxidative stress and risk of cardiovascular events in patients with coronary artery disease Circulation 104 2673 2678 10.1161/hc4601.099485 1:CAS:528:DC%2BD38Xht1CitQ%3D%3D 11723017
13. RR Engel CH Rich O Receveur AH Smith 1994 Vascular effects of chronic arsenic exposure: a review Epidemiol Rev 16 184 209 1:STN:280: DyaK2M3ivVOqtg%3D%3D 7713176
14. MM Wu HY Chiou IC Ho CJ Chen TC Lee 2003 Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects Environ Health Perspect 111 1429 1438 1:CAS:528:DC%2BD3sXnsVSmtLg%3D 12928151
15. A Barchowsky RR Roussel LR Klei PE James N Ganju KR Smith, et al. 1999 Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways Toxicol Appl Pharmacol 159 65 75 10.1006/taap.1999.8723 1:CAS:528:DyaK1MXltFSgs7k%3D 10448126 (Pubitemid 29404762)
16. M Bunderson JD Coffin HD Beall 2004 Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis Toxicol Appl Pharmacol 201 32 39 10.1016/j.taap.2004.04.008 1:CAS:528:DC%2BD2cXpt1Wju7k%3D 15519606 (Pubitemid 39446324)
17. TC Tsou FY Tsai YW Hsieh LA Li SC Yen LW Chang 2005 Arsenic induces cytotoxicity by down-regulation of vascular endothelial nitric oxide synthase Toxicol Appl Pharmacol 208 277 284 10.1016/j.taap.2005.03.001 1:CAS:528:DC%2BD2MXhtFCjsrrK 16239170 (Pubitemid 41457229)
18. S Lynn JR Gurr HT Lai KY Jan 2000 NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells Circ Res 86 514 519 1:CAS:528:DC%2BD3cXitFWhu7c%3D 10720412
19. KR Smith LR Klei A Barchowsky 2001 Arsenite stimulates plasma membrane NAD(P)H oxidase in vascular endothelial cells Am J Physiol Lung Cell Mol Physiol 280 442 449
20. P Balakumar S Jindal M Singh 2007 Novel use of uric acid and sodium arsenite to induce vascular endothelial dysfunction J Pharmacol Toxicol 2 437 446 10.3923/jpt.2007.437.446 1:CAS:528:DC%2BD2sXhtV2rsb7K
21. S Jindal M Singh P Balakumar 2008 Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats Int J Cardiol 128 383 391 10.1016/j.ijcard.2007.05.031 17658639
22. E Berrone E Beltramo C Solimine 2006 Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cell cultured in high glucose J Biol Chem 281 9307 9313 10.1074/jbc.M600418200 1:CAS:528:DC%2BD28XjtVSrsbw%3D 16452468 (Pubitemid 43864646)
23. S Wu J Ren 2006 Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-α Neurosci Lett 394 158 162 10.1016/j.neulet.2005.10.022 1:CAS:528:DC%2BD28XjsF2gtw%3D%3D 16260089 (Pubitemid 43061479)
24. S Dimmeler I Fleming B Fisslthaler C Hermann R Busse AM Zeiher 1999 Activation of nitric oxide synthase in endothelial cells by Akt dependent phosphorylation Nature 399 601 605 10.1038/21224 1:CAS:528:DyaK1MXjvFegu7s%3D 10376603 (Pubitemid 29279182)
25. DI Shah M Singh 2007 Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats Mol Cell Biochem 295 65 74 10.1007/s11010-006-9273-9 1:CAS:528:DC%2BD2sXosFKjtQ%3D%3D 16841179 (Pubitemid 46157988)
26. DI Shah M Singh 2007 Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction Int J Cardiol 120 317 324 10.1016/j.ijcard.2006.10.006 17240464 (Pubitemid 47069557)
27. Marchetti V, Menghinni R, Rizza S, Vivanti A, Feccia T, Lauro D, Fukamizu A, Lauro R, Federici M (2006) Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FOXO signaling. Diabetes 55:2231-2237
28. S Gadau C Emanueli SV Linthout G Graiani M Todaro M Meloni I Campesi G Invernici F Spillmann K Ward P Madeddu 2006 Benfotaimine accelerate the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis Diabetologia 49 405 420 10.1007/s00125-005-0103-5 1:CAS:528:DC%2BD28XhtFWmsrk%3D 16416271 (Pubitemid 43185412)
29. P Balakumar R Sharma M Singh 2008 Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in rats Pharmacol Res 58 356 363 10.1016/j.phrs.2008.09.012 1:CAS:528:DC%2BD1cXhsVChu77I 18951979
30. S Mittra M Singh 1998 Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta Mol Cell Biochem 183 63 67 10.1023/A:1006854313163 1:CAS:528:DyaK1cXktVehsrw%3D 9655179 (Pubitemid 28263888)
31. DI Shah M Singh 2006 Possible role of exogenous cAMP to improve vascular endothelial dysfunction in hypertensive rats Fundam Clin Pharmacol 20 595 604 10.1111/j.1472-8206.2006.00449.x 1:CAS:528:DC%2BD2sXltlA%3D 17109653 (Pubitemid 44760178)
32. HT Malczak RC Buck 1997 Regeneration of endothelium in rat aorta after local freezing Am J Pathol 86 133 148
33. JCK Lai EM Tranfield DC Walker J Dyck A Kerjner S Loo D Wong PC McDonald MH Moghadasian EW Janet BM McManus 2003 Ultra structural evidence of early endothelial damage in coronary arteries of rat cardiac allografts J Heart Lung Transplant 22 993 1004 10.1016/S1053-2498(02)01163-4 12957609 (Pubitemid 37075938)
34. KV Sastry RP Moudgal J Mohan JS Tyagu GS Rao 2002 Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy Annal Biochem 306 79 82 10.1006/abio.2002.5676 1:CAS:528:DC%2BD38XksFOnsrc%3D (Pubitemid 34722019)
35. MA Ibrahim H Asai S Satoh N Satoh S Ueda 2004 Effect of zaprinast on nitric oxide levels in serum and aortic tissue Meth Find Exp Clin Pharmacol 26 19 24 10.1358/mf.2004.26.1.793468 1:CAS:528:DC%2BD2cXis1Wks70%3D (Pubitemid 38295507)
36. OH Lowry NJ Rosebrough AL Farr RJ Randall 1951 Protein measurement with the folin phenol reagent J Biol Chem 193 265 275 1:CAS:528:DyaG38XhsVyrsw%3D%3D 14907713
37. FX Ma LY Liu XM Xiong 2003 Protective effects of lovastatin on vascular endothelium injured by low density lipoprotein Acta Pharmacol Sin 24 1027 1032 1:CAS:528:DC%2BD3sXotFSksr0%3D 14531947
38. HD Wang PJ Pagano Y Du AJ Cayatte MT Quinn 1998 Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide Circ Res 82 810 818 1:STN:280:DyaK1c3itV2isA%3D%3D 9562441
39. JC States S Srivastava Y Chen A Barchowsky 2008 Arsenic and cardiovascular diseases Toxicol Sci 107 312 323 10.1093/toxsci/kfn236 19015167
40. Y Kumagai J Pi 2004 Molecular basis for arsenic-induced alteration in nitric oxide production and oxidative stress: implication of endothelial dysfunction Toxicol Appl Pharmacol 198 450 457 10.1016/j.taap.2003.10.031 1:CAS:528:DC%2BD2cXmtVahsrw%3D 15276426 (Pubitemid 38976520)
41. S Pennathur JW Heinecke 2007 Oxidative stress and endothelial dysfunction in vascular disease Curr Diabetes Rep 10 257 264 10.1007/s11892-007-0041-3 (Pubitemid 47249084)